Literature DB >> 1562617

High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease.

P J Foxall1, R G Price, J K Jones, G H Neild, F D Thompson, J K Nicholson.   

Abstract

High field 1H-NMR spectra of fluid collected from the cysts of six renal transplant recipients with autosomal dominant polycystic kidney disease (ADPKD) have been measured and the major metabolite signals assigned. Quantitative NMR measurements have revealed a combination of unusual biochemical features of the cystic fluids that shows them to be distinct from both blood plasma and urine. Isoleucine, lysine, threonine and valine were present at mM concentrations, in cyst fluid and in some cases levels up to 2 orders of magnitude higher than normal plasma or urine were recorded. Mean glucose concentrations in the cyst fluids ranged from 3.4-9.6 mM and a number of organic acids and bases, including acetate, lactate, succinate, creatinine and dimethylamine were also present at high concentration and in different ratios to those found in either plasma or urine. The majority of cyst fluids examined also contained significant quantities of glycoproteins with characteristic 1H-NMR signals from N-acetyl groups of amino-sugar and sialic acid side chains which had a high degree of molecular mobility (as indicated by their relatively long T2 relaxation times, greater than 120 ms). High levels of ethanol (0.5-12.6 mM/l) were found in all fluid samples from the six transplanted patients (confirmed by conventional analysis). In general there was little variation in the 1H-NMR spectral patterns of either the intra- or interpatient cyst fluids, although the contribution of the protein macromolecules to individual spectra was lower in a few cysts. This constancy of biochemical composition probably reflects the chronic nature of the accumulation of cyst fluid and a long turnover of the cystic fluid components which has the effect of averaging composition. These findings suggest that the dynamic composition of cyst fluid from ADPKD patients is unique among the other body fluids and that the unusual composition may be related to epithelial polarity reversal of the cystic epithelium which could also contribute to the growth of the cysts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562617     DOI: 10.1016/0925-4439(92)90008-b

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys.

Authors:  R Attar; F Quinn; P J Winyard; P D Mouriquand; P Foxall; M A Hanson; A S Woolf
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 2.  Unravelling the pathogenesis of cystic kidney diseases.

Authors:  A S Woolf; P J Winyard
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

3.  Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Lauren Pickel; Ioan-Andrei Iliuta; James Scholey; York Pei; Hoon-Ki Sung
Journal:  Adv Nutr       Date:  2021-11-10       Impact factor: 8.701

4.  Analysis of fetal and neonatal urine using proton nuclear magnetic resonance spectroscopy.

Authors:  P J Foxall; S Bewley; G H Neild; C H Rodeck; J K Nicholson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-11       Impact factor: 5.747

5.  2-Deoxy-d-Glucose Ameliorates PKD Progression.

Authors:  Marco Chiaravalli; Isaline Rowe; Valeria Mannella; Giacomo Quilici; Tamara Canu; Veronica Bianchi; Antonia Gurgone; Sofia Antunes; Patrizia D'Adamo; Antonio Esposito; Giovanna Musco; Alessandra Boletta
Journal:  J Am Soc Nephrol       Date:  2015-11-03       Impact factor: 10.121

6.  Influence of Freezing and Storage Procedure on Human Urine Samples in NMR-Based Metabolomics.

Authors:  Manuela J Rist; Claudia Muhle-Goll; Benjamin Görling; Achim Bub; Stefan Heissler; Bernhard Watzl; Burkhard Luy
Journal:  Metabolites       Date:  2013-04-09

Review 7.  Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review.

Authors:  Abdul-Hamid Emwas; Claudio Luchinat; Paola Turano; Leonardo Tenori; Raja Roy; Reza M Salek; Danielle Ryan; Jasmeen S Merzaban; Rima Kaddurah-Daouk; Ana Carolina Zeri; G A Nagana Gowda; Daniel Raftery; Yulan Wang; Lorraine Brennan; David S Wishart
Journal:  Metabolomics       Date:  2014-11-21       Impact factor: 4.290

8.  Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.

Authors:  Isaline Rowe; Marco Chiaravalli; Valeria Mannella; Valeria Ulisse; Giacomo Quilici; Monika Pema; Xuewen W Song; Hangxue Xu; Silvia Mari; Feng Qian; York Pei; Giovanna Musco; Alessandra Boletta
Journal:  Nat Med       Date:  2013-03-24       Impact factor: 53.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.